Axsome Therapeutics Ownership | Who Owns Axsome Therapeutics?
Axsome Therapeutics Ownership Summary
Axsome Therapeutics is owned by 14.38% institutional investors, 16.45% insiders, and 69.17% retail investors. Vanguard group is the largest institutional shareholder, holding 8.11% of AXSM shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.69% of its assets in Axsome Therapeutics shares.
AXSM Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Axsome Therapeutics | 14.38% | 16.45% | 69.17% |
Sector | Healthcare Stocks | 76.85% | 9.87% | 13.27% |
Industry | Biotech Stocks | 60.77% | 9.77% | 29.45% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Vanguard group | 3.90M | 8.11% | $330.19M |
Blackrock funding, inc. /de | 3.53M | 7.34% | $298.96M |
Blackrock | 3.30M | 6.96% | $265.65M |
Rtw investments, lp | 2.92M | 5.98% | $340.88M |
Bvf inc/il | 1.69M | 3.46% | $197.13M |
Fairmount funds management | 1.47M | 3.05% | $124.29M |
Fmr | 1.00M | 2.08% | $84.65M |
Macquarie group | 964.05K | 2.00% | $81.57M |
State street | 947.25K | 1.97% | $80.15M |
Geode capital management | 912.54K | 1.90% | $77.23M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Alethea capital management | 734.32K | 53.19% | $62.13M |
Fairmount funds management | 1.47M | 12.36% | $124.29M |
Bvf inc/il | 1.69M | 8.03% | $197.13M |
Rtw investments, lp | 2.92M | 5.21% | $340.88M |
Ally bridge group (ny) | 66.66K | 4.84% | $5.64M |
Pfm health sciences, lp | 556.54K | 4.71% | $64.91M |
Tri locum partners lp | 249.77K | 4.38% | $21.13M |
Svb capital management | 33.85K | 4.12% | $2.86M |
Ghost tree capital | 150.00K | 3.78% | $12.07M |
Iridian asset management llc/ct | 125.08K | 2.82% | $10.58M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Lazard asset management | 537.67K | 0.07% | 451.74K |
Norges bank | 403.03K | 0.00% | 403.03K |
Orbimed advisors | 386.70K | 1.08% | 386.70K |
Bvf inc/il | 1.69M | 8.03% | 302.16K |
Millennium management | 235.31K | 0.01% | 231.06K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Rtw investments, lp | 2.92M | 5.21% | -1.13M |
Ra capital management | - | - | -1.00M |
Fairmount funds management | 1.47M | 12.36% | -891.09K |
Deep track capital, lp | - | - | -857.22K |
Hood river capital management | - | - | -644.78K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Norges bank | 403.03K | 0.00% | 403.03K | $34.10M |
Orbimed advisors | 386.70K | 1.08% | 386.70K | $45.10M |
Raymond james financial | 174.59K | 0.01% | 174.59K | $14.77M |
Man group | 163.39K | 0.04% | 163.39K | $13.82M |
Marshall wace, llp | 127.10K | 0.01% | 127.10K | $10.75M |
Sold Out
Holder | Change |
---|---|
Financial gravity asset management | -1.00 |
Geowealth management | -5.00 |
Allspring global investments | -9.00 |
Capital performance advisors llp | -10.00 |
Nelson, van denburg & campbell wealth management group | -10.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 19 | -94.14% | 7,027,292 | -81.11% | 14 | 0.24% | 8 | -94.97% | 9 | -90.00% |
Dec 31, 2024 | 319 | 3.57% | 37,149,265 | -2.97% | 77 | 1.22% | 153 | 15.04% | 90 | -1.10% |
Sep 30, 2024 | 307 | 12.45% | 38,233,493 | -6.12% | 79 | 1.08% | 131 | 15.93% | 93 | -1.06% |
Jun 30, 2024 | 271 | -3.21% | 40,700,359 | 6.09% | 85 | 1.20% | 112 | -17.04% | 93 | 17.72% |
Mar 31, 2024 | 280 | 6.87% | 38,362,452 | -0.55% | 84 | 1.26% | 135 | 20.54% | 79 | -11.24% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard US Total Market Shares ETF | 1.31M | 2.69% | 114.89K |
Vanguard Total Stock Mkt Idx Inv | 1.25M | 2.57% | 4.33K |
Vanguard Small Cap Index | 979.33K | 1.99% | 5.51K |
iShares Russell 2000 ETF | 908.99K | 1.85% | 154.00 |
Vanguard Institutional Extnd Mkt Idx Tr | 626.13K | 1.28% | 8.22K |
Macquarie Small Cap Core I | 596.59K | 1.22% | 16.96K |
Delaware Small Cap Core I | 579.64K | 1.21% | -3.59K |
Vanguard Small Cap Growth Index Inv | 545.24K | 1.11% | -729.00 |
Bellevue Healthcare Ord | 506.57K | 1.06% | 506.57K |
Fidelity Small Cap Growth | 460.70K | 0.94% | 43.35K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
May 20, 2025 | Coleman Mark | - | Sell | $322.47K |
Feb 13, 2025 | Pizzie Nick | Chief Financial Officer | Sell | $1.56M |
Feb 14, 2025 | Pizzie Nick | Chief Financial Officer | Sell | $393.21K |
Sep 11, 2024 | Saad Mark E | - | Sell | $1.01M |
Aug 09, 2024 | Jacobson Mark L. | Chief Operating Officer | Sell | $4.02M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | 1 |
2025 Q1 | - | 2 |
2024 Q4 | - | - |
2024 Q3 | - | 2 |
2024 Q2 | - | 4 |
AXSM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools